Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

about

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.

P2860

Q53686708-0D8685E2-0EDB-401E-B4EE-68C045EFB72B

P2860

Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

Item

http://www.wikidata.org/entity/Q36997917

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

@en

type

Item

label

Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

@en

prefLabel

Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

@en

P1476

Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

@en

P2093

Anna Bagnato

http://www.w3.org/2001/XMLSchema#string

Laura Rosanò

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analyses of ovarian carcinoma

Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.

Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.

Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells

Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.

Endothelin 1 in cancer: biological implications and therapeutic opportunities.

Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.

Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.

P304

e995025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/23723556.2014.995025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laura Rosanò

Anna Bagnato

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276455552

http://www.w3.org/2001/XMLSchema#string

P698

27308478

http://www.w3.org/2001/XMLSchema#string

P932

4905315

http://www.w3.org/2001/XMLSchema#string

Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

about

P2860

P2860

Disrupting the endothelin and Wnt relationship to overcome chemoresistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932